<SEC-DOCUMENT>0001437749-26-019253.txt : 20260603
<SEC-HEADER>0001437749-26-019253.hdr.sgml : 20260603
<ACCEPTANCE-DATETIME>20260603060301
ACCESSION NUMBER:		0001437749-26-019253
CONFORMED SUBMISSION TYPE:	6-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20260630
FILED AS OF DATE:		20260603
DATE AS OF CHANGE:		20260603

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ALTERITY THERAPEUTICS LTD
		CENTRAL INDEX KEY:			0001131343
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				000000000
		STATE OF INCORPORATION:			C3
		FISCAL YEAR END:			0630

	FILING VALUES:
		FORM TYPE:		6-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-49843
		FILM NUMBER:		261058794

	BUSINESS ADDRESS:	
		ADDRESS IS A NON US LOCATION: 	YES
		STREET 1:		LEVEL 3, 460 BOURKE STREET
		CITY:			MELBOURNE
		PROVINCE COUNTRY:   	C3
		BUSINESS PHONE:		61 3 9349 4906

	MAIL ADDRESS:	
		ADDRESS IS A NON US LOCATION: 	YES
		STREET 1:		LEVEL 3, 460 BOURKE STREET
		CITY:			MELBOURNE
		PROVINCE COUNTRY:   	C3

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	PRANA BIOTECHNOLOGY LTD
		DATE OF NAME CHANGE:	20010105
</SEC-HEADER>
<DOCUMENT>
<TYPE>6-K
<SEQUENCE>1
<FILENAME>athe20260603c_6k.htm
<DESCRIPTION>FORM 6-K
<TEXT>
<html><head>
	<title>athe20260603c_6k.htm</title>
	<!-- Generated by ThunderDome Portal - 6/3/2026 7:11:50 AM --><meta charset="utf-8"><meta name="format-detection" content="telephone=no">
</head>
<body style="font-size: 10pt; font-family: &quot;Times New Roman&quot;; padding: 0in 0.1in; cursor: auto;">
<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>SECURITIES AND EXCHANGE COMMISSION</b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Washington, D.C. 20549</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>FORM 6-K</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>REPORT OF FOREIGN PRIVATE ISSUER</b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>PURSUANT TO RULE 13a-16 OR 15d-163</b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>UNDER THE SECURITIES EXCHANGE ACT OF 1934</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>For the month of June&nbsp;2026</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Alterity Therapeutics Limited</b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">(Name of Registrant)</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Level 15, 500 Collins Street, Melbourne, Victoria 3000 Australia</b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">(Address of Principal Executive Office)</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Form 20-F &#9746;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Form 40-F &#9744;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"><b>This Form 6-K is being incorporated by reference into our Registration Statement on Form S-8 (Files No. </b><a href="http://www.sec.gov/Archives/edgar/data/1131343/000121390020040485/ea130838-s8_alteritytherape.htm" style="-sec-extract:exhibit;"><b><u>333-251073</u></b></a><b>, </b><a href="http://www.sec.gov/Archives/edgar/data/1131343/000121390020027969/ea127207-s8_alteritytherap.htm" style="-sec-extract:exhibit;"><b><u>333-248980</u></b></a><b> and </b><a href="http://www.sec.gov/Archives/edgar/data/1131343/000114420418063081/tv508429_s-8.htm" style="-sec-extract:exhibit;"><b><u>333-228671</u></b></a><b>) and our Registration Statements on Form F-3 (Files No. </b><a href="http://www.sec.gov/Archives/edgar/data/1131343/000101376223000033/ea185947-f3_alteritytherape.htm" style="-sec-extract:exhibit;"><b><u>333-274816</u></b></a><b>, </b><a href="http://www.sec.gov/Archives/edgar/data/1131343/000121390020044324/ea132148-f3_alteritytherape.htm" style="-sec-extract:exhibit;"><b><u>333-251647</u></b></a><b>, </b><a href="http://www.sec.gov/Archives/edgar/data/1131343/000114420419025615/tv521271_f3.htm" style="-sec-extract:exhibit;"><b><u>333-231417</u></b></a><b> and </b><a href="http://www.sec.gov/Archives/edgar/data/1131343/000121390020036934/ea129831-f3_alteritytherap.htm" style="-sec-extract:exhibit;"><b><u>333-250076</u></b></a><b>)</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<div contenteditable="false" data-applyto="p" data-auto-pgnum="start" data-displaynum="1" data-fontname="Times New Roman" data-fontsize="10pt" data-numstyle="a" data-prefix="" data-startnum="1" data-suffix="" data-textalign="center">&nbsp;</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>ALTERITY THERAPEUTICS LIMITED</b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>(a development stage enterprise)</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The following exhibits are submitted:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 36pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">99.1</p>
			</td>
			<td style="width: auto;"><a href="ex_971457.htm" style="-sec-extract:exhibit;">Change of Registered Office Address</a></td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="1" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">1</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><u>SIGNATURE</u></b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tr>
			<td style="vertical-align:top;width:auto;">&nbsp;</td>
			<td colspan="2" style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Alterity Therapeutics Limited</b></p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:32.1%;">&nbsp;</td>
			<td style="vertical-align:top;width:2.1%;">&nbsp;</td>
			<td style="vertical-align:top;width:19.2%;">&nbsp;</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:auto;">&nbsp;</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">By:</p>
			</td>
			<td style="vertical-align: top; width: auto; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">/s/ Julian Babarczy</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:auto;">&nbsp;</td>
			<td style="vertical-align:top;width:auto;">&nbsp;</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Julian Babarczy</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:auto;">&nbsp;</td>
			<td style="vertical-align:top;width:auto;">&nbsp;</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Chairman</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Date: June 3, 2026</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="LAST-PAGE-BREAK">
<div class="PGFTR">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="2" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">2</div>
</div>
</div>
</div>


</body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>ex_971457.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<html><head>
	<title>ex_971457.htm</title>
	<!-- Generated by ThunderDome Portal - 6/3/2026 7:13:36 AM --><meta charset="utf-8"><meta name="format-detection" content="telephone=no">
</head>
<body style="font-size: 10pt; font-family: &quot;Times New Roman&quot;; padding: 0in 0.1in; cursor: auto;">
<p style="margin: 0px 0pt; text-align: right; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt"><b>Exhibit 99.1</b></font></p>

<p style="margin: 0px 0pt; text-align: left; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font></p>

<p style="text-align:center;font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"><img alt="logo.jpg" src="logo.jpg"></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:12pt;font-variant:normal;text-align:center;margin:0pt 0pt 0pt 8pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:12pt;font-variant:normal;text-align:center;margin:0pt 0pt 0pt 8pt;"><b>Change of Registered Office Address </b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"><b>MELBOURNE, AUSTRALIA AND SAN FRANCISCO, USA </b>&#8211;<b> 3 June 2026:</b>&nbsp; Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) (&#8220;Alterity&#8221; or &#8220;the Company&#8221;) wishes to advise that for the purposes of ASX Listing Rule 3.14, the Company&#8217;s registered office address has changed to the below, effective 3 June 2026.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"><b>Address: </b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">Level 15, 500 Collins Street</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">Melbourne</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">VIC 3000.</p>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</p>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</p>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><b>This announcement was authorised by the Board of Directors of Alterity Therapeutics Limited.</b></p>

<div class="LAST-PAGE-BREAK">
<div class="PGFTR">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>
</div>


</body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>logo.jpg
<TEXT>
begin 644 logo.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  (! 0(! 0(" @(" @(" P4# P,#
M P8$! ,%!P8'!P<&!P<("0L)" @*" <'"@T*"@L,# P,!PD.#PT,#@L,# S_
MVP!# 0(" @,# P8# P8," <(# P,# P,# P,# P,# P,# P,# P,# P,# P,
M# P,# P,# P,# P,# P,# P,# P,# S_P  1"  U -P# 2(  A$! Q$!_\0
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M*G>'?%NI^ M)\1:=!X/O([.[&K0)&9'<,5*;6/'RYKZH#<<D9[TIQY-& M%
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MRRQ16MR^W[%K=IG?#MZ9DC##/<JHK>M#VE#5W:*.H_X/%S_QDI\ ?^P==?\
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M7 9\._V9M$^%WQ[^('Q#LKK49M7^)'V$:A#-(#!!]DB:./RQCC(/->7^(_\
M@G-92_%77O&'@3XB^/OA>/%]XNH>)-*T&YB^PZS<#;NGV2(QAE=0%9XR":**
MI,#U#XY_!G4OC?X,L=.TGQQXI\!WUK*EU#J6BR1&8@#:8I4E1DE0YR0R]:\K
M^$7_  3-^&?P8T;4K:_@U7Q?K6MZE-K&JZQJ-UY-Q?W4P7>Y2 )&O"KPJ@<4
(45<-78:1_]D!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
